Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-01-09
1992-03-17
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
435119, 4352521, 435867, 546 36, A61K 3144, C07D47100, C12P 1718, C12N 112
Patent
active
050969072
ABSTRACT:
This disclosure describes novel antibacterial agents designated LL-E10985.alpha., LL-E19085.beta., LL-E19085.gamma., LL-E19085.gamma. and LL-E19085.zeta., having the structure: ##STR1## their production by aerobic fermentation of a new subspecies of Micromonospora citrea NRRL 18351 and mutants thereof, and the isolation and purification thereof.
REFERENCES:
patent: 4666715 (1987-05-01), Omura et al.
Maiese, W. M. et al., (Jun. 1989), "LL-E19085.alpha., A Novel Antibiotic from Micromonospora CITREA", The Journal of Antibiotics, vol. 42, pp. 846-851.
Nakawaga, A. et al. (1986) "Enhanced Antimicrobial Activity of Acetyl Derivatives of Cervinomycin". The Journal of Antibiotics, vol. 39, pp. 1636-1638.
Carter Guy T.
Goodman Joseph J.
Labeda David P.
American Cyanamid Company
Dow Kenneth J.
Robinson Douglas W.
Weber Susan M.
LandOfFree
Antibiotic LL-E19085 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibiotic LL-E19085, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibiotic LL-E19085 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1476068